Bay State Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.

Press releases published on October 1, 2026

Huntress Accelerates European Expansion Through New ALSO Partnership
Christina McKitish, Highlighted By Influential Women, Connects Deep Education And Wellness Through Journey Forward Yoga
Influential Women Spotlights Tammi Hayes: A Life Lived Fully, In Her Mother’s Honor
Choate Adds 11-Lawyer Litigation Team from Kasowitz, Accelerating its Growth in New York
Pixability Launches New Solution to Help Advertisers Avoid ‘AI Slop’ on YouTube
Connolly Brothers completes new 127,120 SF self-storage facility in Canton, Massachusetts
Heilind Electronics Now Stocking Molex Rely-On Connectors for Harsh-Environment, Space-Constrained Designs
Progress Software Connects Enterprise Knowledge Across Business Systems with New Agentic RAG Capabilities
HealthEdge Launches Unified AI-Powered Platform to Guarantee Financial Outcomes for Health Plans 
AI Is Reshaping Gene Transfer Technologies — $258.7 Billion in VC Signals a Structural Shift in Biotech Investment
MDaudit to Spotlight eValuator™ at AHIMA26
Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic
Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing
Legato Frames, the World’s First AI-Based Hearing Glasses, Are Now Available in the U.S.
Vima Therapeutics to Present New Research at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
Akari Therapeutics Expands Intellectual Property Portfolio with PCT Filing for ADC Payload Related to RNA Splicing in Cancers
Candel Therapeutics Announces Publication of Phase 2a Trial Data that Demonstrated Prolonged Survival after Systemic Immune Reactivation by Aglatimagene Besadenovec plus Valacyclovir in Patients with Unresectable Stage III/IV NSCLC with an Inadequate…
Life Biosciences to Present First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies at Eyecelerator 2026
Sophos Launches CISO Advantage, Bringing CISO-Level Security Strategy Within Reach of Every Organization
Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Bay State Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.